EST
ZYME icon

EA Series Trust’s Zymeworks ZYME Stock Holding History

EA Series Trust’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$1.97M Buy
+228,373
New +$2.04M 0.07% 398

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

EA Series Trust's ZYME Position: Q2 2023 in Review

EA Series Trust opened a new position in Zymeworks (ZYME) in Q2 2023: 228,373 shares worth $1.97M. The stake represents 0.07% of the portfolio and ranks #398 among its holdings.

137 funds tracked by Wall St. Rank hold ZYME as of Q2 2023.

  • EA Series Trust held 228,373 shares of Zymeworks worth $1.97M as of Q2 2023.
  • Zymeworks was a new EA Series Trust position in Q2 2023.
  • Zymeworks made up 0.07% of EA Series Trust's portfolio in Q2 2023, its #398 holding.
  • 137 funds tracked by Wall St. Rank held Zymeworks as of Q2 2023.

Based on EA Series Trust's 13F filing for Q2 2023, filed 27 Jul 2023.